FDA DrugClass IINotable

FDA Recall: Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx o

Date: 2026-04-22
Brand: The Harvard Drug Group LLC
Category: Drug
FDA Class: Class II

Description

Failed Dissolution Specifications

Hazard

Failed Dissolution Specifications

Remedy

N/A

View original recall →
Share:

Related Recalls

2026-04-29 · FDA_DRUG
FDA Recall: Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per
The Harvard Drug Group LLC
2026-03-11 · FDA_DRUG
FDA Recall: Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and
The Harvard Drug Group LLC